Literature DB >> 17174450

Translational gene mapping of cognitive decline.

Beth Wilmot1, Shannon K McWeeney, Randal R Nixon, Thomas J Montine, Jamie Laut, Christina A Harrington, Jeffrey A Kaye, Patricia L Kramer.   

Abstract

The ability to maintain cognitive function during aging is a complex process subject to genetic and environmental influences. Alzheimer's disease (AD) is the most common disorder causing cognitive decline among the elderly. Among those with AD, there is broad variation in the relationship between AD neuropathology and clinical manifestations of dementia. Differences in expression of genes involved in neural processing pathways may contribute to individual differences in maintenance of cognitive function. We performed whole genome expression profiling of RNA obtained from frontal cortex of clinically non-demented and AD subjects to identify genes associated with brain aging and cognitive decline. Genetic mapping information and biological function annotation were incorporated to highlight genes of particular interest. The candidate genes identified in this study were compared with those from two other studies in different tissues to identify common underlying transcriptional profiles. In addition to confirming sweeping transcriptomal differences documented in previous studies of cognitive decline, we present new evidence for up-regulation of actin-related processes and down-regulation of translation, RNA processing and localization, and vesicle-mediated transport in individuals with cognitive decline.

Entities:  

Mesh:

Year:  2006        PMID: 17174450      PMCID: PMC2684335          DOI: 10.1016/j.neurobiolaging.2006.11.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  70 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

Review 2.  Genetic evidence for cognitive reserve: variations in memory and related cognitive functions.

Authors:  Joseph H Lee
Journal:  J Clin Exp Neuropsychol       Date:  2003-08       Impact factor: 2.475

Review 3.  The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases.

Authors:  Andrew Singleton; Amanda Myers; John Hardy
Journal:  Hum Mol Genet       Date:  2004-02-19       Impact factor: 6.150

Review 4.  How frequent is altered gene expression among susceptibility genes to human complex disorders?

Authors:  Philippe H Jais
Journal:  Genet Med       Date:  2005-02       Impact factor: 8.822

Review 5.  Small regulatory RNAs in mammals.

Authors:  John S Mattick; Igor V Makunin
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

6.  Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria.

Authors:  H Braak; E Braak
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

7.  nRap GEP: a novel neural GDP/GTP exchange protein for rap1 small G protein that interacts with synaptic scaffolding molecule (S-SCAM).

Authors:  T Ohtsuka; Y Hata; N Ide; T Yasuda; E Inoue; T Inoue; A Mizoguchi; Y Takai
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

Review 8.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

9.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

Authors:  L M Bierer; P R Hof; D P Purohit; L Carlin; J Schmeidler; K L Davis; D P Perl
Journal:  Arch Neurol       Date:  1995-01

10.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

View more
  13 in total

Review 1.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

Review 3.  Intersectin scaffold proteins and their role in cell signaling and endocytosis.

Authors:  Erika Herrero-Garcia; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-10-12       Impact factor: 4.739

4.  Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.

Authors:  Michael P Hunter; Marianela Nelson; Michael Kurzer; Xuerong Wang; Richard J Kryscio; Elizabeth Head; Graziano Pinna; John P O'Bryan
Journal:  Neuroreport       Date:  2011-10-26       Impact factor: 1.837

Review 5.  Intersecting pathways in cell biology.

Authors:  John P O'Bryan
Journal:  Sci Signal       Date:  2010-12-14       Impact factor: 8.192

6.  Concerted perturbation observed in a hub network in Alzheimer's disease.

Authors:  Dapeng Liang; Guangchun Han; Xuemei Feng; Jiya Sun; Yong Duan; Hongxing Lei
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

7.  The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease-old wine in new bottles.

Authors:  Karl H Braunewell
Journal:  Front Mol Neurosci       Date:  2012-02-23       Impact factor: 5.639

Review 8.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

Review 9.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

10.  Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.

Authors:  Olga Novokhatska; Mykola Dergai; Liudmyla Tsyba; Inessa Skrypkina; Valeriy Filonenko; Jacques Moreau; Alla Rynditch
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.